CDER New October 7, 2015

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

October 6, 2015


New and Generic Drug Approvals

October 5, 2015

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Gattex Kit teduglutide recombinant Powder;Subcutaneous Nps Pharms Inc Manufacturing Change or Addition
Glucotrol Xl glipizide Tablet, Extended Release;Oral Pfizer Labeling Revision
Ic-Green indocyanine green Injectable;Injection Akorn Labeling Revision
Olmesartan Medoxomil olmesartan medoxomil Tablet;Oral Torrent Pharms Ltd Tentative Approval
Olysio simeprevir sodium Capsule;Oral Janssen Prods Efficacy Supplement with Clinical Data to Support
Tobi tobramycin Solution;Inhalation Novartis Pharms Labeling Revision

 


This email was sent to rssproject471@gmail.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery

Postingan terkait:

Belum ada tanggapan untuk "CDER New October 7, 2015"

Post a Comment